Alerts will be sent to your verified email
Verify Email
FERMENTA
|
Fermenta Biotech
|
Advanced Enzyme
|
Concord Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
2.59 % | 10.41 % | 2.26 % |
|
Financials
|
|||
|
5 yr Average ROE
|
2.76 % | 10.77 % | 20.02 % |
|
5yr average Equity Multiplier
|
1.95 | 1.15 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
0.59 | 0.41 | 0.52 |
|
5yr Avg Net Profit Margin
|
2.17 % | 22.63 % | 30.81 % |
|
Price to Book
|
2.94 | 2.84 | 10.04 |
|
P/E
|
13.86 | 30.74 | 48.97 |
|
5yr Avg Cash Conversion Cycle
|
-30.1 Days | 109.31 Days | 37.41 Days |
|
Inventory Days
|
127.88 Days | 77.49 Days | 80.96 Days |
|
Days Receivable
|
64.16 Days | 61.31 Days | 111.87 Days |
|
Days Payable
|
154.92 Days | 49.86 Days | 173.13 Days |
|
5yr Average Interest Coverage Ratio
|
2.37 | 54.21 | 137.55 |
|
5yr Avg ROCE
|
10.4 % | 14.52 % | 25.59 % |
|
5yr Avg Operating Profit Margin
|
14.91 % | 35.47 % | 42.97 % |
|
5 yr average Debt to Equity
|
0.54 | 0.02 | 0.04 |
|
5yr CAGR Net Profit
|
11.05 % | -2.12 % | 12.77 % |
|
5yr Average Return on Assets
|
1.67 % | 9.32 % | 15.93 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
64.09 % | 43.08 % | 44.08 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
4.51 % | -9.62 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -0.59 % | -0.9 % |
|
Fermenta Biotech
|
Advanced Enzyme
|
Concord Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|